Abraham Scaria
Company: Beacon Therapeutics
Job title: Chief Scientific Officer
Seminars:
Chair’s Closing Remarks 5:00 pm
day: Day Two 12th
Panel Discussion: Maximizing Ophthalmic Gene Therapy Trial Success Strategies 9:30 am
Discussing strategies for improving trial design to mitigate risks and enhance success Exploring the regulatory landscape and its impact on gene therapy trials, including approval processes and compliance requirements Detailing actionable steps derived from past failures to inform future gene therapy endeavours and maximize trial outcomesRead more
day: Day Two 12th
Chair’s Opening Remarks 8:50 am
day: Day Two 12th